Hasil Pencarian - Vernon K Sondak

Perbaiki Hasil
  1. 1
    Nonsurgical Treatment Options for Basal Cell Carcinoma

    Nonsurgical Treatment Options for Basal Cell Carcinoma oleh Mary H. Lien, Vernon K. Sondak

    Diterbitkan 2011-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    A rare sweat gland tumor in an ovarian teratoma: Spiradenocylindroma case report

    A rare sweat gland tumor in an ovarian teratoma: Spiradenocylindroma case report oleh Mariah Vesely, Atousa Ordobazari, Jane Messina, Mahsa Chitsaz, Vernon K. Sondak, Monica Avila

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Higher than reported adolescent and young adult clinical trial enrollment during the “Golden Age” of melanoma clinical trials

    Higher than reported adolescent and young adult clinical trial enrollment during the “Golden Age” of melanoma clinical trials oleh Radhika Sreeraman Kumar, Ram Thapa, Youngchul Kim, Nikhil I. Khushalani, Vernon K. Sondak, Damon R. Reed

    Diterbitkan 2018-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512.

    Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512. oleh Shailender Bhatia, James Moon, Kim A Margolin, Jeffrey S Weber, Christopher D Lao, Megan Othus, Ana M Aparicio, Antoni Ribas, Vernon K Sondak

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Radar-Guided Localization and Resection for Metastatic Nodal and Soft Tissue Melanoma: A Single-Institution Retrospective Study

    Radar-Guided Localization and Resection for Metastatic Nodal and Soft Tissue Melanoma: A Single-Institution Retrospective Study oleh Kate E. Beekman, Danielle K. DePalo, Lily M. Parker, Kelly M. Elleson, John E. Mullinax, Amod A. Sarnaik, Vernon K. Sondak, Jonathan S. Zager

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Clinicopathologic predictors of survival in patients with desmoplastic melanoma.

    Clinicopathologic predictors of survival in patients with desmoplastic melanoma. oleh Dale Han, Gang Han, Xiuhua Zhao, Nikhil G Rao, Jane L Messina, Suroosh S Marzban, Amod A Sarnaik, C Wayne Cruse, Vernon K Sondak, Jonathan S Zager

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Cutaneous Human Papillomavirus Infection and Development of Subsequent Squamous Cell Carcinoma of the Skin

    Cutaneous Human Papillomavirus Infection and Development of Subsequent Squamous Cell Carcinoma of the Skin oleh Shalaka S. Hampras, Rhianna A. Reed, Spencer Bezalel, Michael Cameron, Basil Cherpelis, Neil Fenske, Vernon K. Sondak, Jane Messina, Massimo Tommasino, Tarik Gheit, Dana E. Rollison

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins

    Re-biopsy of partially sampled thin melanoma impacts sentinel lymph node sampling as well as surgical margins oleh Evan S Weitman, Matthew C Perez, Daniel Lee, Youngchul Kim, William Fulp, Vernon K Sondak, Amod A Sarnaik, Ricardo J Gonzalez, Carl W Cruse, Jane L Messina, Jonathan S Zager

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma

    Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma oleh Joseph Markowitz, Ahmad A Tarhini, Zeynep Eroglu, Evan J Wuthrick, Andrew S Brohl, Nikhil I Khushalani, Vernon K Sondak, Lilit Karapetyan, Tanya Ramadoss, Matthew Nichols, Christian Palacios, Kenneth Y Tsai

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Melanoma and CLL co-occurrence and survival: role of KC history

    Melanoma and CLL co-occurrence and survival: role of KC history oleh Yayi Zhao, Rossybelle P. Amorrortu, Sandra C. Stewart, Kavita M. Ghia, Vonetta L. Williams, Vernon K. Sondak, Kenneth Y. Tsai, Javier Pinilla-Ibarz, Julio C. Chavez, Dana E. Rollison

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience.

    Clinical Characteristics and Outcomes for Solitary Fibrous Tumor (SFT): A Single Center Experience. oleh Nicholas DeVito, Evita Henderson, Gang Han, Damon Reed, Marilyn M Bui, Robert Lavey, Lary Robinson, Jonathan S Zager, Ricardo J Gonzalez, Vernon K Sondak, G Douglas Letson, Anthony Conley

    Diterbitkan 2015-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    The “Great Debate” at Melanoma Bridge 2020: December, 5th, 2020

    The “Great Debate” at Melanoma Bridge 2020: December, 5th, 2020 oleh Paolo A. Ascierto, Michael B. Atkins, Alexander M. Eggermont, Jeffrey E. Gershenwald, Jean-Jacques Grob, Omid Hamid, Vernon K. Sondak, Jeffrey A. Sosman, Hussein A. Tawbi, Jeffrey S. Weber, Corrado Caracò, Iman Osman, Igor Puzanov

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience

    Interferon is associated with improved survival for node-positive cutaneous melanoma: a single-institution experience oleh Daniel E Oliver, Vernon K Sondak, Tobin Strom, Jonathan S Zager, Arash O Naghavi, Amod Sarnaik, Jane L Messina, Jimmy J Caudell, Andy M Trotti, Javier F Torres-Roca, Nikhil I Khushalani, Louis B Harrison

    Diterbitkan 2018-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

    Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary oleh Lisa H Butterfield, Howard Streicher, Patrick Hwu, Walter J Storkus, Ahmad A Tarhini, John M Kirkwood, F Stephen Hodi, Vernon K Sondak, Jose R Conejo-Garcia, Sandra J Lee, Aik-Choon Tan, Issam M El Naqa, William A LaFramboise, Arivarasan D Karunamurthy

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males

    Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to ma... oleh Mariam Saad, Sandra J. Lee, Aik Choon Tan, Issam M. El Naqa, F. Stephen Hodi, Lisa H. Butterfield, William A. LaFramboise, Walter Storkus, Arivarasan D. Karunamurthy, Jose Conejo-Garcia, Patrick Hwu, Howard Streicher, Vernon K. Sondak, John M. Kirkwood, Ahmad A. Tarhini

    Diterbitkan 2022-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    625 Immune priming IFx-Hu2.0 promotes antibody responses necessary for anti-PD1 responses in PD-1 refractory melanoma patients

    625 Immune priming IFx-Hu2.0 promotes antibody responses necessary for anti-PD1 responses in PD-1 refractory melanoma patients oleh Joseph Markowitz, Shari Pilon-Thomas, Amod A Sarnaik, Pei-ling Chen, Ahmad A Tarhini, Zeynep Eroglu, Andrew S Brohl, Nikhil I Khushalani, Vernon K Sondak, Youngchul Kim, Michael Shamblott, Christopher W Dukes, Alejandra Chamizo, Marina Bastawrous, Edward Garcia, Ashraf Delhawi, Deanryan BDe Aquino, Patricia Lawman

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanomaResearch in context

    Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanomaResearch in context oleh Inna Smalley, Eunjung Kim, Jiannong Li, Paige Spence, Clayton J. Wyatt, Zeynep Eroglu, Vernon K. Sondak, Jane L. Messina, Nalan Akgul Babacan, Silvya Stuchi Maria-Engler, Lesley De Armas, Sion L. Williams, Robert A. Gatenby, Y. Ann Chen, Alexander R.A. Anderson, Keiran S.M. Smalley

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series

    Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series oleh Erin McClure BS, Michael J Carr MD, MS, Ayushi Patel BS, Syed Mahrukh Hussnain Naqvi MD, MPH, Youngchul Kim PhD, Michael Harrington MD, Wayne Cruse MD, Ricardo J Gonzalez MD, Vernon K Sondak MD, Amod A Sarnaik MD, Jane L Messina MD, Jonathan S Zager MD

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer oleh Christopher A Barker, Evan J Lipson, Harriet Kluger, Brian R Gastman, Michael T Tetzlaff, Igor Puzanov, Shailender Bhatia, Paul Nghiem, Ann W Silk, Zeynep Eroglu, Sunandana Chandra, Isaac Brownell, Anna C Pavlick, David M Miller, Vernon K Sondak, Kari L Kendra, Kathryn B Bollin, Kathleen Madden, Guilherme Rabinowits, Emily S Ruiz, Edward A Tavss

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis

    Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis oleh F Stephen Hodi, Ahmad A Tarhini, John M Kirkwood, Zeynep Eroglu, Henry B Koon, Ni Kang, Vernon K Sondak, Harriet M Kluger, Sandra J Lee, Gary I Cohen, Laura F Hutchins, Donald P Lawrence, Kari L Kendra, David R Minor, Carrie B Lee, Mark R Albertini, Lawrence E Flaherty, Teresa M Petrella

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: